USANA Health Sciences, Inc. (NYSE:USNA) Director John Turman Fleming Sells 500 Shares

USANA Health Sciences, Inc. (NYSE:USNA - Get Free Report) Director John Turman Fleming sold 500 shares of USANA Health Sciences stock in a transaction dated Monday, June 9th. The shares were sold at an average price of $29.66, for a total value of $14,830.00. Following the transaction, the director now owns 4,200 shares in the company, valued at $124,572. This trade represents a 10.64% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website.

USANA Health Sciences Price Performance

NYSE USNA traded down $1.02 on Wednesday, hitting $29.84. 112,465 shares of the stock were exchanged, compared to its average volume of 134,989. The business's fifty day moving average is $27.74 and its 200 day moving average is $31.28. USANA Health Sciences, Inc. has a 52 week low of $23.10 and a 52 week high of $48.85. The company has a market capitalization of $555.75 million, a PE ratio of 10.54, a P/E/G ratio of 0.93 and a beta of 0.63.

USANA Health Sciences (NYSE:USNA - Get Free Report) last announced its quarterly earnings results on Tuesday, April 22nd. The company reported $0.73 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.70 by $0.03. The business had revenue of $249.54 million during the quarter, compared to the consensus estimate of $243.08 million. USANA Health Sciences had a return on equity of 10.64% and a net margin of 6.30%. During the same quarter last year, the firm posted $0.86 EPS. Analysts predict that USANA Health Sciences, Inc. will post 2.45 EPS for the current fiscal year.

Institutional Inflows and Outflows

Several large investors have recently bought and sold shares of USNA. US Bancorp DE increased its stake in shares of USANA Health Sciences by 13.1% during the first quarter. US Bancorp DE now owns 4,611 shares of the company's stock worth $124,000 after purchasing an additional 535 shares during the period. Exchange Traded Concepts LLC increased its position in USANA Health Sciences by 7.1% during the 1st quarter. Exchange Traded Concepts LLC now owns 9,184 shares of the company's stock worth $248,000 after buying an additional 606 shares during the period. PNC Financial Services Group Inc. lifted its holdings in shares of USANA Health Sciences by 339.6% during the first quarter. PNC Financial Services Group Inc. now owns 998 shares of the company's stock worth $27,000 after buying an additional 771 shares in the last quarter. Martingale Asset Management L P boosted its position in shares of USANA Health Sciences by 5.4% in the first quarter. Martingale Asset Management L P now owns 17,542 shares of the company's stock valued at $473,000 after acquiring an additional 900 shares during the period. Finally, Versant Capital Management Inc grew its stake in shares of USANA Health Sciences by 542.5% in the first quarter. Versant Capital Management Inc now owns 1,150 shares of the company's stock valued at $31,000 after acquiring an additional 971 shares in the last quarter. 54.25% of the stock is owned by institutional investors.

Wall Street Analyst Weigh In

USNA has been the topic of a number of recent research reports. Wall Street Zen raised USANA Health Sciences from a "hold" rating to a "buy" rating in a research report on Thursday, May 22nd. Sidoti cut USANA Health Sciences from a "strong-buy" rating to a "hold" rating in a report on Tuesday, February 18th. Finally, DA Davidson decreased their price target on USANA Health Sciences from $38.00 to $36.00 and set a "neutral" rating for the company in a research note on Thursday, February 27th.

About USANA Health Sciences

USANA Health Sciences, Inc develops, manufactures, and sells science-based nutritional, personal care, and skincare products in the Asia Pacific, the Americas, and Europe. The company offers USANA nutritional products that comprise essentials/CellSentials, such as vitamin and mineral supplements that provide a foundation of total body nutrition for various age groups; optimizers consisting of targeted supplements that are designed to meet cardiovascular, skeletal/structural, and digestive health needs; and food that include meal replacement shakes, snack bars, and other related products.